Psychedelics and Autism

Psychedelics and autism is one of the 'psychedelics and ...' topics that we're currently making a page for. At this moment you can find all papers (in our database) on this topic below.

Research Papers Compared Measured Researchers Gaps Companies

State of Research

TBD

Quality of Conclusions

TBD

Data Points

TBD Papers studying this directly
TBD Companies working on this

Access all our research

Become a free member now to get unlimited access.

Receive our weekly update on the latest psychedelic research, make (private) notes on pages, and download our reports.

Our vision is that psychedelics can be used worldwide to better the lives of as many as 450 million people who suffer from mental health problems. Our information hopes to make that vision come to life just a little faster.

Autism Research

Here will be a narrative, readable, summary of the research.

Papers

In our literature study we came across the following studies of note. Browse the meta, review, commentary articles for an overview. Check out the individual studies for specific experiments and observations.

A Systematic Review of the MDMA Model to Address Social Impairment in Autism

2021 | Albrecht, M., Chaliha, D., Lam, V., Mamo, J. C., Takechi, R., Vaccarezza, M.

This systematic review (2021) examines whether MDMA can treat social impairments of autism, and draws supporting evidence from animal models which indicate MDMA-induced prosocial behaviors.

The use of psychedelic agents with autistic schizophrenic children

1971 | Aldrich, R. W., Mogar, R. E.

This review (1971) of 7 studies looked at the effect of psychedelics in autistic children (n=91). Psychedelics led to improved speech and mood, better emotional responsiveness, and decreased compulsive behaviour.

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

2020 | Bathje, G. J., Chwyl, C., Davis, A. K., Lancelotta, R., Luoma, J. B.

This meta-analysis of nine placebo-controlled trials (n=211) showed a very large effect size (g=1.21) of treatment on four mental health conditions (PTSD, end-of-life anxiety, depression, social anxiety among autistic adults).

Autistic Schizophrenic Children: An Experiment in the Use of D-Lysergic Acid Diethyladmide (LSD-25)

1977| Freedman, A. M.

This early study (1962; n=12) with LSD (50-200µg) on children with autism (ASD) and schizophrenia, of which 7 were mute, showed that LSD elicited large psychological changes in this population, but no change in muteness. Procedures for consent were different/non-existent at that time.

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study

2018| Danforth, A. L., Emerson, A., Feduccia, A. A., Grob, C. S., Jerome, L., Struble, C., Walker, N., Yazar-Klosinski, B.

This double-blind, placebo-controlled, randomized pilot study (n=12) found a significant reduction in social anxiety (d=1.4) after MDMA-assisted psychotherapy (75-125mg, 2 sessions). The effects persisted even 6-months later (d=1.1).

Compared

This section compares the research with psychedelics to other therapies, medicines, or treatments.

Measured

This section highlights the various measures used and their use in research.

Researchers

Who are the top researches in this area, the ones who have done the groundbreaking research.

Gaps

What do we not know at this time? Where are the gaps in our knowledge and are we closing it?

Companies

The companies that are actively engaged in researching this topic or (planning to) provide therapy focussed on this topic.

Outside Academia

This section highlights everything done outside of academia, from popular press to books and non academic research.